Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Optimal Management of Vascular Disease 2014: Current Concepts and Controverseries


Published on

  • Be the first to comment

  • Be the first to like this

Optimal Management of Vascular Disease 2014: Current Concepts and Controverseries

  1. 1. Taj Boston Boston, Massachusetts 342510 Vascular and Endovascular Surgery_252424.1 1/16/14 12:36 PM Page 2 Optimal Management of Vascular Disease 2014: Current Concepts and Controversies COURSE DIRECTORS: DAVID C. BREWSTER, M.D. & GLENN M. LAMURAGLIA, M.D. Delivering the 2014 Linton Lecture - David C. Brewster, M.D. THURSDAY APRIL 24 - SATURDAY APRIL 26, 2014 Taj Boston • Boston, Massachusetts HARVARD MEDICAL SCHOOL MASSACHUSETTS GENERAL HOSPITAL Division of Vascular and Endovascular Surgery
  2. 2. 342510 Vascular and Endovascular Surgery_252424.1 1/16/14 12:36 PM Page 3 Optimal Management of Vascular Disease 2014: Current Concepts and Controversies COURSE DESCRIPTION This course is intended to provide an in-depth examination of a spectrum of topics related to the management of patients with vascular disease. A comprehensive review of existing data as well as new information regarding the natural history, pathogenesis, diagnosis and treatment of commonly encountered vascular problems will be presented by an outstanding faculty of over 40 nationally recognized authorities leading to a better understanding of contemporary standards of effective and cost-efficient care as well as future trends in vascular surgery. The wide scope of this course allows the faculty to provide current updates and advances in many areas of vascular surgery and to indicate the advantages and possible disadvantages of varying methods of management for a wide variety of problems in vascular surgery. By providing up to date information and data on current therapies, the course will improve clinicians’ competence, performance and patient outcomes. By encouraging active audience participation and a panel session at the conclusion of each session of the course, we can solidify factual knowledge and clarify proper indications for use of different treatment modalities The teaching modalities in this course include: didactic lectures, panel discussions, question and answer sessions, video demonstrations, and group case discussions. COURSE OBJECTIVES Care of vascular diseases is undergoing rapid change, with much new knowledge and shifts in therapies toward less invasive treatments. The proper role of such new treatments, and their use in place of more traditional open surgical interventions, remains highly controversial. This course is aimed at addressing such controversies and clarifying the clinical circumstances most appropriate for different treatments and interventions. Upon completion of this activity, participants will be able to: • Describe the indications for intervention in carotid artery disease • Improve clinical decision-making regarding appropriate interventions for carotid endarterectomy • Determine the advantages and disadvantages of carotid stenting • Evaluate the best available options for treating lower extremity ischemia • Utilize endovascular therapies for peripheral artery occlusive disease as appropriate • Manage acute arterial ischemia according to current Society for Vascular Surgery guidelines • Apply the current guidelines for aortic aneurysm management • Provide care for venous disease in keeping with recent evidence and recommendations TARGET AUDIENCE The target audience for the course includes vascular, general or cardiothoracic surgeons, as well as interventional radiologists or cardiologists treating vascular diseases. In addition, nurse practitioners or other allied health providers involved in the diagnosis and management of vascular disease will benefit from the broad coverage of the course. Residents and Fellows in training are welcome to attend. ACCREDITATION The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Harvard Medical School designates this live activity for a maximum of 19.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ACGME COMPETENCIES This course is designed to meet one or more of the following Accreditation Council of Graduate Medical Education competencies: • Medical Knowledge • Practice-Based Learning and Improvement
  3. 3. 342510 Vascular and Endovascular Surgery_252424.1 1/16/14 12:36 PM Page 4 Mark D. Iafrati, M.D. Tufts Medical Center Michael Belkin, M.D. Brigham and Women’s Hospital Michael Jaff, D.O. Massachusetts General Hospital Elizabeth Blazick, M.D. Massachusetts General Hospital Jeffrey A. Kalish, M.D. Boston Medical Center David C. Brewster, M.D. Massachusetts General Hospital Christopher J. Kwolek, M.D. Massachusetts General Hospital Clayton Brinster, M.D. Massachusetts General Hospital Glenn M. LaMuraglia, M.D. Massachusetts General Hospital Richard P. Cambria, M.D. Massachusetts General Hospital Robert T. Lancaster, M.D. Massachusetts General Hospital David R. Campbell, M.D. Beth Israel Deaconess Medical Center and Joslin Diabetes Center William C. Mackey, M.D. Tufts Medical Center Nancy L. Cantelmo, M.D. Massachusetts General Hospital Elliot Chaikof, M.D. Beth Israel Deaconess Medical Center W. Darrin Clouse, M.D. University of California-Davis Medical Center Mark F. Conrad, M.D. Massachusetts General Hospital R. Clement Darling III, M.D. The Vascular Group, Albany NY Mohammed Eslami, M.D. Boston Medical Center James M. Estes, M.D. Tufts Medical Center Chieh-Min Fan, M.D. Brigham and Women’s Hospital Alik Farber, M.D. Boston Medical Center Joseph Garasic, M.D. Massachusetts General Hospital Raul J. Guzman, M.D. Beth Israel Deaconess Medical Center John (Jeb) W. Hallett, Jr., M.D. Roper Saint Francis Heart and Vascular Center George H. Meier, M.D. University of Cincinnati 2014 FACULTY Elias J. Arous, M.D. University of Massachusetts Medical Center Matthew T. Menard, M.D. Brigham and Women’s Hospital Louis L. Nguyen, M.D. Brigham and Women’s Hospital Thomas F. O’Donnell, M.D. Tufts Medical Center Virendra I. Patel, M.D. Massachusetts General Hospital Bruce A. Perler, M.D., M.B.A. The Johns Hopkins Hospital Frank B. Pomposelli, M.D. Saint Elizabeth’s Medical Center Robert M. Schainfeld, M.D. Massachusetts General Hospital Andres Schanzer, M.D. University of Massachusetts Medical Center Lee H. Schwamm, M.D. Massachusetts General Hospital Sherry D. Scovell, M.D. Massachusetts General Hospital Michael T. Watkins, M.D. Massachusetts General Hospital JOIN US APRIL 24-26 AND ENJOY ALL THAT BOSTON HAS TO OFFER
  4. 4. 342510 Vascular and Endovascular Surgery_252424.1 1/16/14 12:36 PM Page 5 THURSDAY, APRIL 24, 2014 7:00 - 7:20 7:20 - 7:30 7:30 7:45 8:00 8:15 - 7:45 8:00 8:15 8:30 Registration Welcome and Introductory Remarks SESSION I: CEREBROVASCULAR DISEASE Can we predict stroke risk in individual patients? Dr. William Mackey Is contralateral stenosis or occlusion a significant risk for CEA? Dr. Virendra Patel What is the role of carotid stenting? A surgeon’s perspective Dr. Bruce Perler Open surgical cervical approach with flow reversal for carotid stenting: Is it a better way? Dr. Chris Kwolek GREAT DEBATE 8:30 - 8:45 8:45 - 9:00 9:00 - 9:30 9:30 - 10:00 10:00 - 10:15 10:15 - 10:30 10:30 - 10:45 10:45 - 11:00 11:00 - 11:15 11:15 - 11:45 11:45 - 1:00 1:00 1:15 1:30 1:45 - 1:15 1:30 1:45 2:00 2:00 - 2:15 2:15 - 2:45 2:45 - 3:15 3:15 3:30 3:45 4:00 4:15 4:30 4:45 - 3:30 3:45 4:00 4:15 4:30 4:45 5:00 5:00 - 5:30 5:30 Patients with asymptomatic carotid stenosis should be treated by modern best medical therapy Dr. Lee Schwamm Are you kidding? CEA remains the best for significant asymptomatic carotid stenosis Dr. Richard Cambria Panel Discussion/Questions BREAK – PLEASE VISIT EXHIBITS SESSION II: LOWER EXTREMITY OCCLUSIVE DISEASE Can treatment with drugs or exercise programs for claudication give outcomes comparable to interventional procedures? Dr. Michael Jaff What is the best strategy for infrainguinal bypass if the saphenous vein is inadequate or unavailable? Do heparin-bonded prosthetic grafts have a role? Dr. Jeb Hallett Can drug-eluting stents or covered stent grafts improve results of L.E. endovascular therapy? Dr. Alik Farber What is the impact of failed L.E. endovascular therapy? Do you burn bridges? Dr. Glenn LaMuraglia What are the indications for lower extremity bypass grafts in the endovascular era? Dr. Bruce Perler Panel Discussion/Questions LUNCH (ON YOUR OWN) – PLEASE VISIT EXHIBITS SESSION III: ANEURYSMAL DISEASE Can AAA rupture risk be predicted? Dr. Elliot Chaikof How I select an endovascular stent graft for EVAR Dr. Clem Darling Chimney and Snorkel grafts as an adjunct to EVAR Dr. Andres Schanzer Technical tips for open juxtarenal AAA repair: Getting better results than complex endovascular procedures Dr. Glenn LaMuraglia What’s on the horizon for endovascular procedures for aneurysmal disease? Dr. Chris Kwolek Panel Discussion/Questions BREAK – PLEASE VISIT EXHIBITS SESSION IV: VASCULAR EMERGENCIES Acute lower extremity ischemia Dr. Raul Guzman Early neurologic deficit following CEA Dr. Frank Pomposelli Acute mesenteric ischemia Dr. Todd Lancaster Tips for open repair of ruptured AAA Dr. Darrin Clouse EVAR for ruptured AAA: Is it a better way? Dr. Clem Darling Acute iliofemoral venous thrombosis with phlegmasia Dr. Mickey Meier Vascular Trauma: exposures, control and potential use of endovascular therapies Dr. Jeffrey Kalish Panel Discussion/Questions ADJOURN
  5. 5. 342510 Vascular and Endovascular Surgery_252424.1 1/16/14 12:36 PM Page 6 FRIDAY, APRIL 25, 2014 SESSION V: CONTEMPORARY TREATMENT OF VENOUS DISEASE 7:30 - 7:40 How to select patients for endo-venous therapies: what work-up do you need? Dr. Sherry Scovell 7:40 - 7:55 Saphenous vein ablation: methods and results Dr. Sherry Scovell 7:55 - 8:15 Updates on foam sclerotherapy and ambulatory phlebectomy Dr. Nancy Cantelmo 8:15 - 8:30 SVS/AVF guidelines for management of venous ulcers 8:30 - 8:45 Updates on current management of DVT 8:45 - 9:15 Dr. Robert Schainfeld Panel Discussion/Questions 9:15 - 9:45 Dr. Thomas O’Donnell BREAK – PLEASE VISIT EXHIBITS SESSION VI: UPDATES IN VASCULAR SURGERY 9:45 - 10:00 Tips for contemporary wound care: Is wet to dry passe? 10:00 - 10:15 Optimal strategies for ESRD hemodialysis access 10:15 - 10:30 Management of dialysis access failures 10:30 - 10:45 Dr. Michael Watkins Dr. Alik Farber Do type II endoleaks after EVAR require treatment? If so, how best to best do it? Dr. Todd Lancaster 10:45 - 11:15 Panel Discussion/Questions 11:15 - 12:00 Linton Lecture (Introduction: Dr. Richard Cambria) Dr. Mark Conrad 12:00 - 1:15 Dr. David Brewster LUNCH (ON YOUR OWN) – PLEASE VISIT EXHIBITS SESSION VII: CURRENT CONTROVERSIES 1:15 - 1:30 1:30 - 1:45 1:45 - 2:00 2:00 - 2:15 When should popliteal aneurysms be treated? Is there a role for stent grafts? Dr. Matt Menard What is the role of renal artery intervention in current practice? Dr. Joseph Garasic Management of acute aortic dissection: Does TEVAR have a place? Dr. Mark Conrad Is tibial occlusive disease with critical limb ischemia best managed by bypass or endovascular therapy? 2:15 - 2:45 Panel Discussion/Questions 2:45 - 3:15 BREAK 3:15 - 3:30 Unusual carotid artery problems: Carotid body tumors, carotid dissection, FMD/aneurysms and Takayasu’s arteritis Dr. Michael Belkin SESSION VIII: CHALLENGING PROBLEMS Dr. Jeb Hallett 3:30 - 3:45 Tips for management of difficult groin wound problems Dr. Darrin Clouse 3:45 - 4:00 Treatment of vascular complications of thoracic outlet syndrome Dr. Louis Nguyen 4:00 - 5:30 VASCULAR ROUNDS Dr. Elizabeth Blazick, Dr. Clay Brinster PROBLEM CASE PRESENTATIONS Moderator: Dr. David Brewster Panelists: Dr. Richard Cambria, Dr. Clem Darling, Dr. Jeb Hallett Dr. Mickey Meier, Dr. Mark Iafrati 5:30 ADJOURN WWW.CME.HMS.HARVARD.EDU/COURSES/VASCULAR
  6. 6. 342510 Vascular and Endovascular Surgery_252424.1 1/16/14 12:36 PM Page 7 SATURDAY, APRIL 26, 2014 7:30 7:45 8:00 8:15 8:30 - 7:45 8:00 8:15 8:30 9:00 9:00 - 9:30 9:30 - 10:00 10:00 10:15 10:30 10:45 - 10:15 10:30 10:45 11:00 11:00 - 11:15 11:15 - 11:30 11:30 - 12:00 12:00 noon SESSION IX: HOW I DO IT (VIDEO SESSION I) How I do venous ablation procedures Dr. Sherry Scovell How I do spine exposures for orthopaedic procedures Dr. Virendra Patel How I do femoropopliteal bypass Dr. Elias Arous Tips for successful femoro-tibial bypass Dr. David Campbell How to get exposure for juxtarenal and suprarenal aortic surgery Dr. Richard Cambria Panel Discussion/Questions BREAK – PLEASE VISIT EXHIBITS SESSION X: HOW I DO IT (VIDEO SESSION II) How I treat May-Thurner Syndrome Dr. Chieh-Min Fan How to do IVC filter insertion and removal Dr. James Estes How I do carotid stents Dr. Chris Kwolek How to successfully treat chronic total occlusions (TCO) Dr. Mohammed Eslami Utility of mechanical thrombectomy devices for arterial and venous occlusions Dr. Mickey Meier How I do EVAR for ruptured AAA: step by step protocol Dr. Clem Darling Panel Discussion/Questions COURSE CONCLUDES Meeting Adjourned Program changes/substitutions may be made without notice. COURSE LOCATION All sessions will be held at the Taj Hotel, 15 Arlington Street, Boston, MA 02116 Telephone: 617-536-5700 ONLINE INFORMATION To register or view activity online, visit: to ensure proper registration, please add the first three characters of the source code found at the bottom of this registration form. DISCLOSURE POLICY Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations. REFUND POLICIES A handling fee of $60 is deducted for cancellation. Refund requests must be received by postal mail, email or fax one week prior to this activity. No refunds will be made thereafter. INQUIRIES By phone (617) 384-8600, Monday-Friday, 10am to 4pm (EST) or by email at:
  7. 7. REGISTRATION INFORMATION Full Fee - $675 (USD) Residents and Fellows in Training - $300 (USD) Allied Health Professionals - $300 (USD) Registration by credit card (VISA, MasterCard or Americah Express) can be made at Registration by check (draft on a United States bank), pleas make check payable to Harvard Medical School and mail with registration form to Harvard Medical School, Department of Continuing Education, P.O. Box 417476, Boston, MA 02241-7476. Telephone or fax registration is not accepted. Registration with cash payment is not permitted. Upon receipt of your paid registration an email confirmation from the HMS-DCE office will be sent to you. Be sure to include an email address that you check frequently. Your email address is used for critical information including: registration confirmation, evaluation and certificate. ACCOMMODATIONS AND TRAVEL A Limited number of rooms have been reserved at the Taj Boston (617-536-5700) until March 26, 2014. Please specify that you are enrolled in this course to receive the reduced room rate of $325 single/double. Please do not purchase non-refundable airline ticket(s) until you have recieved an email from our office confirming your paid registration. For airfare reservations contact the HMS Travel Desk toll free 1-877-4-HARVMD (1-877-442-7863) Monday - Friday 9 am to 8 pm (EST). From outside the U.S., Canada and Virgin Islands, please call (617) 599-3764. VASCULAR AND ENDOVASCULAR SURGERY COURSE # 342510 APRIL 24-26, 2014 Please Check One: m Physicians m Residents/Fellows in Training m Allied Health Professionals $675 (USD) $300 (USD) $300 (USD) Total Tuition Enclosed: $ _________ ALL FIELDS REQUIRED. PLEASE PRINT CLEARLY. __________________________________________________________________________________________________________________________________ Full Name (First, Middle Initial, Last) __________________________________________________________________________________________________________________________________ Address (Street) __________________________________________________________________________________________________________________________________ City State Zip Code __________________________________________________________________________________________________________________________________ Daytime Phone Fax Number Please note: Your email address is used for critical information about the course including; registration confirmation, evaluation and certificate. Please be sure to include an email address you check daily or frequently. __________________________________________________________________________________________________________________________________ Email Address m Please check if you wish to be excluded from receiving email notices of future Harvard Medical School - Department of Continuing Education programs. __________________________________________________________________________________________________________________________________ Profession __________________________________________________________________________________________________________________________________ Primary Specialty (Physicians Only) Board Certified? m Yes m No __________________________________________________________________________________________________________________________________ Professional School Attended (Physicians Only) m Harvard Medical School m U.S. Medical School m International Year of Graduation _______________ : Online registrants - add the first three characters of the source code found here  Source Code: 1EMB A C D E F G X Z Z Z